Clinical Report: The Truth About Softgels: Phthalate-Free, Powered by Glycerin and Sorbitol

Overview

This report clarifies misconceptions regarding the use of phthalates in softgel capsules, emphasizing that no phthalates are used in their production. It highlights the safety of glycerin and sorbitol as plasticizers in softgel formulations, while noting that low molecular weight phthalates are approved for use in some medicinal products.

Background

Concerns have been raised about phthalates in softgel capsules, particularly regarding their potential health risks, including links to cardiovascular issues. Understanding the composition of softgel capsules is crucial for healthcare professionals to address patient concerns accurately.

Data Highlights

No numerical data or trial results were presented in the source material.

Key Findings

• No phthalates are used as plasticizers in softgel capsules manufactured by Catalent.
• Phthalates are primarily found in tablets and powder-filled capsules, not in softgels.
• Low molecular weight phthalates are approved for use in some medicinal products but are not associated with significant toxicity risks.
• Glycerin and sorbitol are the primary plasticizers used in softgel capsules, with a long-standing safety record.
• Consumers can verify the absence of phthalates by checking ingredient listings on product packaging.

Clinical Implications

Healthcare professionals should reassure patients that softgel capsules do not contain harmful phthalates, alleviating concerns about potential health risks. It is important to guide patients on how to verify product ingredients to ensure safety.

Conclusion

The evidence indicates that softgel capsules are safe and do not pose a risk of phthalate exposure. Ongoing education about the composition of these products is essential for informed patient care.

References

1. FDA, Limiting the Use of Certain Phthalates as Excipients in CDER-Regulated Products, 2023 -- Guidance for Industry
2. Phthalate exposure from plastics and cardiovascular disease: global estimates of attributable mortality and years life lost, ScienceDirect, 2025 -- Study Analysis
3. Contact Lens Spectrum — product spectrum
4. Endocrine Reviews — Glycerol and Glycerol-3-Phosphate: Multifaceted Metabolites in Metabolism, Cancer, and Other Diseases
5. Optometric Management — Eyedrops to Change Iris Color Under Scrutiny
6. Ophthalmology Management — The New Science Behind Artificial Tears
7. Glycerol and Glycerol-3-Phosphate: Multifaceted Metabolites in Metabolism, Cancer, and Other Diseases
8. Eyedrops to Change Iris Color Under Scrutiny
9. Limiting the Use of Certain Phthalates as Excipients in CDER-Regulated Products | FDA
10. Phthalate exposure from plastics and cardiovascular disease: global estimates of attributable mortality and years life lost - ScienceDirect
11. Shell Formulation in Soft Gelatin Capsules : Advanced Healthcare Materials